Page last updated: 2024-08-17

colchicine and Acute Symptom Flare

colchicine has been researched along with Acute Symptom Flare in 23 studies

Research

Studies (23)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (21.74)24.3611
2020's18 (78.26)2.80

Authors

AuthorsStudies
Cardoso Nóbrega, V; Curcelli, EC; Junior, LAJ; Luiz da Silva, D; Martins, D; Matchil, NL; Okoshi, MP; Pacca, RL; Padovani de Toledo Moraes, M; Padovese, V; Pereira, FWL; Queiroz, DS; Silva, AM; Tonon, CR1
Dalbeth, N; He, Y; Hu, S; Li, C; Li, X; Lu, J; Ran, Z; Shi, Y; Sun, M; Terkeltaub, R; Wang, C; Xu, X; Xue, X; Yan, F; Yin, H; Zhang, H1
Arman, S1
Bilchick, KC; Chinn, ME; Dunn, SP; Mazimba, S; Roth, ME1
Geng, H; Hu, S; Jia, E; Jiang, Y; Xiao, M; Xiao, Y; Xie, J; Zhang, J; Zhu, H1
Ding, Y; Ding, Z; Huang, Z; Ji, S; Liu, Y; Zang, Y; Zhang, J; Zhu, X1
Cui, TJ; Lei, Y; Tang, C; Wang, XH; Zhang, XM; Zheng, ZH1
Chen, HC; Wei, JC; Yang, DH1
Nidorf, SM1
Chapman, PT; Dalbeth, N; Drake, J; Frampton, C; Haslett, J; Horne, A; Mihov, B; Stamp, L1
Ayaz, NA; Çakan, M; Karadağ, ŞG; Sönmez, HE; Tanatar, A1
Avery, A; Blagojevic-Bucknall, M; Clarkson, K; Hartshorne, L; Hay, EM; Heneghan, C; Hooper, J; Hughes, G; Jowett, S; Lewis, M; Little, P; Mahtani, KR; Mallen, CD; McCartney, K; Mehta, R; Nunan, D; Oppong, R; Roddy, E; Santer, M; Williams, S1
Parperis, K1
Mallen, CD; Roddy, E1
Chen, J; Cheng, Y; Li, J; Liang, F; Tang, H; Xu, G; Yin, Z; Zheng, H; Zheng, Q1
Antón-Vázquez, V; Corominas, H; Cortes, C; Farré, EG; Hausmann, JS1
Ahn, SM; Hong, S; Kim, YG; Lee, CK; Oh, JS; Yoo, B1
Alessio, M; Barone, P; Breda, L; Bustaffa, M; Calzatini, F; Cantarini, L; Capozio, G; Carrabba, MD; Cattalini, M; Celani, C; Conti, G; Fabio, G; Gaggiano, C; Gallizzi, R; Gattorno, M; Insalaco, A; Lancieri, M; Maggio, MC; Magnolia, MG; Marrani, E; Mazza, F; Miniaci, A; Montin, D; Moressa, V; Mussinelli, R; Obici, L; Olivieri, AN; Orlando, F; Ricci, F; Rigante, D; Ruperto, N; Simonini, G; Spagnolo, A; Sutera, D1
Carvalho, P; Courville, P; Deschamps, A; Joly, P; Levesque, H; Musette, P; Samain, A1
Fujimori, S; Hidaka, Y; Ide, Y; Inoue, K; Kim, H; Sugimoto, M; Tamaki, S; Taniguchi, A; Yamamoto, T; Yamanaka, H1
Janssen, CA; Oude Voshaar, MAH; Ten Klooster, PM; van de Laar, MAFJ; Vonkeman, HE1
Ea, HK; Graf, S; Guggenbuhl, P; Lioté, F; Norberciak, L; Pascart, T1
Kelly, RI; Wee, E1

Reviews

1 review(s) available for colchicine and Acute Symptom Flare

ArticleYear
Seeing Colchicine in a New Light: Repurposing Low-dose Colchicine for Secondary Prevention of Cardiovascular Disease.
    Clinical therapeutics, 2023, Volume: 45, Issue:11

    Topics: Anti-Inflammatory Agents; Atherosclerosis; Cardiovascular Diseases; Colchicine; Coronary Artery Disease; Drug Repositioning; Gout; Humans; Secondary Prevention; Symptom Flare Up

2023

Trials

5 trial(s) available for colchicine and Acute Symptom Flare

ArticleYear
Zhengqing fengtongning sustained-release tablets prevents gout flares in the process of ULT: A randomized, positive control, double-blind, double-simulation, multicenter trial.
    Medicine, 2022, May-06, Volume: 101, Issue:18

    Topics: Arthritis, Gouty; Colchicine; Delayed-Action Preparations; Double-Blind Method; Drugs, Chinese Herbal; Gout; Gout Suppressants; Humans; Symptom Flare Up; Tablets; Treatment Outcome; Uric Acid

2022
Early urate-lowering therapy in gouty arthritis with acute flares: a double-blind placebo controlled clinical trial.
    European journal of medical research, 2023, Jan-06, Volume: 28, Issue:1

    Topics: Arthritis, Gouty; Chronic Disease; Colchicine; Gout; Gout Suppressants; Humans; Probenecid; Symptom Flare Up; Uric Acid

2023
Is colchicine prophylaxis required with start-low go-slow allopurinol dose escalation in gout? A non-inferiority randomised double-blind placebo-controlled trial.
    Annals of the rheumatic diseases, 2023, Volume: 82, Issue:12

    Topics: Adult; Allopurinol; Colchicine; Gout; Gout Suppressants; Humans; Symptom Flare Up; Treatment Outcome; Uric Acid

2023
Open-label randomised pragmatic trial (CONTACT) comparing naproxen and low-dose colchicine for the treatment of gout flares in primary care.
    Annals of the rheumatic diseases, 2020, Volume: 79, Issue:2

    Topics: Colchicine; Female; Gout; Gout Suppressants; Humans; Male; Middle Aged; Naproxen; Primary Health Care; Symptom Flare Up; Treatment Outcome

2020
Stepwise dose increase of febuxostat is comparable with colchicine prophylaxis for the prevention of gout flares during the initial phase of urate-lowering therapy: results from FORTUNE-1, a prospective, multicentre randomised study.
    Annals of the rheumatic diseases, 2018, Volume: 77, Issue:2

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Colchicine; Dose-Response Relationship, Drug; Febuxostat; Gout; Gout Suppressants; Humans; Incidence; Male; Middle Aged; Prospective Studies; Symptom Flare Up; Uric Acid

2018

Other Studies

17 other study(ies) available for colchicine and Acute Symptom Flare

ArticleYear
Gout Storm.
    The American journal of case reports, 2021, Sep-20, Volume: 22

    Topics: Colchicine; Gout; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Symptom Flare Up; Uric Acid

2021
Colchicine prophylaxis is associated with fewer gout flares after COVID-19 vaccination.
    Annals of the rheumatic diseases, 2022, Volume: 81, Issue:8

    Topics: Adult; Colchicine; COVID-19; COVID-19 Vaccines; Cross-Sectional Studies; Gout; Gout Suppressants; Humans; Symptom Flare Up; Vaccination; Vaccines

2022
How safe and effective is the use of colchicine for the treatment of gout flares? A Cochrane Review summary with commentary.
    International journal of rheumatic diseases, 2022, Volume: 25, Issue:5

    Topics: Colchicine; Gout; Gout Suppressants; Humans; Symptom Flare Up

2022
Association of colchicine use for acute gout with clinical outcomes in acute decompensated heart failure.
    Clinical cardiology, 2022, Volume: 45, Issue:7

    Topics: Colchicine; Gout; Heart Failure; Hospitalization; Humans; Retrospective Studies; Symptom Flare Up

2022
Transdermal delivery of colchicine using dissolvable microneedle arrays for the treatment of acute gout in a rat model.
    Drug delivery, 2022, Volume: 29, Issue:1

    Topics: Administration, Cutaneous; Animals; Arthritis, Gouty; Colchicine; Drug Delivery Systems; Gout; Rats; Symptom Flare Up

2022
Plasma adsorption in refractory chronic gouty arthritis flare: A case report.
    Frontiers in immunology, 2022, Volume: 13

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Gouty; Colchicine; Cytokines; Gout; Humans; Inflammation Mediators; Interleukin-6; Male; Middle Aged; Pain; Symptom Flare Up; Tumor Necrosis Factor-alpha; Uric Acid

2022
The Value of Serum Amyloid A Levels in Familial Mediterranean Fever to Identify Occult Inflammation During Asymptomatic Periods.
    Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2021, Jan-01, Volume: 27, Issue:1

    Topics: Age of Onset; Asymptomatic Diseases; Blood Sedimentation; C-Reactive Protein; Child; Colchicine; Correlation of Data; Familial Mediterranean Fever; Female; Humans; Inflammation; Longitudinal Studies; Male; Patient Acuity; Serum Amyloid A Protein; Sex Factors; Symptom Flare Up; Tubulin Modulators; Turkey

2021
Open-label randomised pragmatic trial (CONTACT) comparing naproxen and low-dose colchicine for the treatment of gout flares in primary care.
    Annals of the rheumatic diseases, 2021, Volume: 80, Issue:12

    Topics: Colchicine; Gout; Gout Suppressants; Humans; Naproxen; Primary Health Care; Symptom Flare Up

2021
Response to: 'Open-label randomised pragmatic trial (CONTACT) comparing naproxen and low-dose colchicine for the treatment of gout flares in primary care' by Parperis
    Annals of the rheumatic diseases, 2021, Volume: 80, Issue:12

    Topics: Colchicine; Gout; Gout Suppressants; Humans; Naproxen; Primary Health Care; Symptom Flare Up

2021
Treatment for acute flares of gout: A protocol for systematic review.
    Medicine, 2020, Volume: 99, Issue:14

    Topics: Acute Disease; Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Bayes Theorem; Colchicine; Cyclooxygenase 2 Inhibitors; Female; Gout; Gout Suppressants; Humans; Male; Middle Aged; Network Meta-Analysis; Randomized Controlled Trials as Topic; Receptors, Interleukin-1; Research Design; Symptom Flare Up; Systematic Reviews as Topic; Treatment Outcome; Young Adult

2020
Adult-Onset Autoinflammatory Syndromes.
    Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2020, Volume: 26, Issue:4

    Topics: Adult; Age of Onset; Antirheumatic Agents; Colchicine; Female; Hereditary Autoinflammatory Diseases; Humans; Immunity, Innate; Immunologic Tests; Interleukin 1 Receptor Antagonist Protein; Interleukin-1; Middle Aged; Mutation; Pyrin; Spain; Symptom Assessment; Symptom Flare Up

2020
Comparative efficacy of low-dose versus regular-dose colchicine to prevent flares in gout patients initiated on urate-lowering therapies.
    Rheumatology (Oxford, England), 2021, 12-24, Volume: 61, Issue:1

    Topics: Adult; Aged; Allopurinol; Cohort Studies; Colchicine; Drug Therapy, Combination; Febuxostat; Female; Gout; Gout Suppressants; Humans; Male; Middle Aged; Retrospective Studies; Symptom Flare Up

2021
Persistence of disease flares is associated with an inadequate colchicine dose in familial Mediterranean fever: A national multicenter longitudinal study.
    The journal of allergy and clinical immunology. In practice, 2021, Volume: 9, Issue:8

    Topics: Colchicine; Familial Mediterranean Fever; Humans; Interleukin 1 Receptor Antagonist Protein; Longitudinal Studies; Symptom Flare Up

2021
A familial mediterranean fever flare induced by a drug reaction with eosinophilia and systemic symptoms.
    Journal of the European Academy of Dermatology and Venereology : JEADV, 2018, Volume: 32, Issue:1

    Topics: Adult; Antirheumatic Agents; Colchicine; Drug Hypersensitivity Syndrome; Familial Mediterranean Fever; Female; Humans; Sulfasalazine; Symptom Flare Up; Tubulin Modulators

2018
Development and validation of a patient-reported gout attack intensity score for use in gout clinical studies.
    Rheumatology (Oxford, England), 2019, 11-01, Volume: 58, Issue:11

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Colchicine; Double-Blind Method; Female; Gout; Humans; Interleukin 1 Receptor Antagonist Protein; Male; Middle Aged; Patient Reported Outcome Measures; Randomized Controlled Trials as Topic; Reproducibility of Results; Sensitivity and Specificity; Severity of Illness Index; Symptom Assessment; Symptom Flare Up

2019
Difficult-to-treat gout flares: eligibility for interleukin-1 inhibition in private practice is uncommon according to current EMA approval.
    Rheumatology (Oxford, England), 2019, 12-01, Volume: 58, Issue:12

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Humanized; Colchicine; Drug Approval; Eligibility Determination; Europe; France; Glucocorticoids; Gout; Gout Suppressants; Humans; Symptom Flare Up

2019
Treatment of nodular vasculitis with colchicine.
    The Australasian journal of dermatology, 2017, Volume: 58, Issue:3

    Topics: Adult; Anti-Inflammatory Agents; Colchicine; Erythema Induratum; Female; Humans; Middle Aged; Prednisolone; Symptom Flare Up; Tubulin Modulators

2017